---
schema_version: "secwatch.filing_event.v1"
accession: "0001370053-23-000023"
form_type: "8-K"
ticker: "ANAB"
cik: "0001370053"
company_name: "ANAPTYSBIO, INC"
filed_at: "2023-04-06T23:59:59+00:00"
generated_at: "2026-06-17T05:01:32.286088+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# AnaptysBio director Laura Hamill resigns; Rita Jain appointed to board and compensation committee

## Summary
- Laura J. Hamill resigned as Class II director effective April 1, 2023; no disagreement with company.
- Rita Jain, M.D. appointed as Class II director and Compensation Committee member effective April 3, 2023.
- Jain receives pro-rata annual retainer: option for 8,015 shares at April 3 closing price, 3,234 RSUs vesting at 2024 annual meeting.
- Additional grants: option for 10,600 shares and 3,900 RSUs, each vesting over three years.

## SEC filing metadata
- accession: 0001370053-23-000023
- form_type: 8-K
- ticker: ANAB
- cik: 0001370053
- company_name: ANAPTYSBIO, INC
- filed_at: 2023-04-06T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1370053/000137005323000023/0001370053-23-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1370053/000137005323000023/anab-20230401.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001370053-23-000023
- JSON: https://secwatch.observer/filing/0001370053-23-000023.json
- Plain text: https://secwatch.observer/filing/0001370053-23-000023.txt

## Key facts
- Executive change
  Rita Jain was appointed as Class II director and member of Compensation Committee at ANAPTYSBIO, INC.
  - Action: appointed
  - Role: Class II director and member of Compensation Committee
  source text: On April 3, 2023, the Board appointed Rita Jain, M.D. as a Class II director and as a member of the Compensation Committee, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1370053/000137005323000023/0001370053-23-000023-index.htm
- Executive change
  Laura J. Hamill resigned as Class II director at ANAPTYSBIO, INC.
  - Action: resigned
  - Role: Class II director
  source text: On April 1, 2023, Laura J. Hamill advised the Board of Directors (the “ Board ”) of AnaptysBio, Inc. (the “ Company ”) that she would resign as a Class II director of the Board, effective on April 1, 2023 (the “ Resignation ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1370053/000137005323000023/0001370053-23-000023-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.